A new oncolytic <i>V</i> <i>accinia</i> <i>virus</i> augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery

Abstract

These data provide a proof of concept for translation of the regime into clinical trials. VVΔTKΔN1L-IL12 is a promising agent for use as an adjuvant to surgical treatment of solid tumors.